What is the recommended titration schedule for propranolol (beta blocker) in a patient with akathisia, considering factors such as age, medical history, and concomitant medications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Propranolol Titration for Akathisia

Start propranolol at 30 mg daily in divided doses (10 mg three times daily) and titrate upward by 10-20 mg every 1-2 days based on response, with most patients responding to 30-80 mg/day within 24 hours. 1

Initial Dosing Strategy

  • Begin with 30 mg/day divided into 2-3 doses (e.g., 10 mg three times daily or 15 mg twice daily), as this represents the lower end of the effective range demonstrated in clinical trials 1
  • Response typically occurs rapidly, within 24 hours in most patients, so you can assess efficacy quickly 1
  • The effective dose range for akathisia is notably lower than for other indications: 30-80 mg/day is sufficient for most patients 1

Titration Schedule

  • Increase by 10-20 mg every 1-2 days if akathisia persists, monitoring for both therapeutic response and adverse effects 1
  • Most patients achieve complete or substantial remission at doses between 30-80 mg/day 1
  • Maximum dose rarely needs to exceed 80 mg/day for akathisia, unlike anxiety or cardiovascular indications where higher doses may be required 2

Pre-Treatment Assessment (Mandatory)

Before initiating propranolol, you must screen for absolute contraindications:

  • Asthma or obstructive airway disease (auscultate lungs for wheezing) 3
  • Second or third-degree heart block (obtain baseline ECG if cardiac history is concerning) 2
  • Decompensated heart failure 2
  • Sinus bradycardia (baseline heart rate <50-55 bpm) 3
  • Hypotension (baseline systolic BP <90 mmHg) 3
  • Recent hypoglycemic episodes (particularly in diabetic patients, as propranolol masks hypoglycemia symptoms) 2, 3

Obtain baseline vital signs including heart rate and blood pressure before the first dose 2, 3

Administration Guidelines

  • Administer with food to reduce hypoglycemia risk, even though this is less critical in adults than pediatric populations 3
  • Divide total daily dose into 2-3 administrations using immediate-release formulation (half-life 3-6 hours requires multiple daily dosing) 2
  • Hold doses if the patient develops acute illness with reduced oral intake or vomiting 3

Monitoring During Titration

  • Measure heart rate and blood pressure before each dose increase, particularly watching for bradycardia (<50-55 bpm) or hypotension (systolic BP <90 mmHg) 2
  • Monitor for orthostatic hypotension, especially in elderly patients or those on concurrent antipsychotics 4
  • Assess akathisia severity at each visit using objective measures (e.g., Barnes Akathisia Rating Scale) to guide titration 4
  • No routine laboratory monitoring is required in otherwise healthy patients 2

Common Pitfalls and Caveats

Propranolol has modest evidence for akathisia despite being considered "first-line" - the evidence base is surprisingly limited, with most data from small open-label trials 4. Alternative agents like low-dose mirtazapine (7.5-15 mg daily) have shown compelling evidence and may be considered if propranolol is contraindicated or ineffective 4

Beta-1 selective agents (metoprolol, betaxolol) are equally effective at doses of 25-100 mg/day for metoprolol or 10-20 mg/day for betaxolol, suggesting beta-1 blockade is sufficient 5, 6. Consider these alternatives in patients with mild reactive airway disease where non-selective beta blockade is relatively contraindicated 5

Propranolol's side effects limit use in some patients, including orthostatic hypotension (particularly problematic when combined with antipsychotics), bradycardia, and fatigue 4. The increased complexity of titration compared to alternatives is a legitimate concern 4

Never abruptly discontinue propranolol after chronic use - taper gradually over 1-3 weeks to prevent rebound tachycardia, hypertension, or worsening akathisia 2, 3

Drug Interactions

  • Avoid combining with non-dihydropyridine calcium channel blockers (diltiazem, verapamil) due to additive effects on cardiac conduction and increased risk of severe bradycardia or heart block 2
  • Use caution with other medications that lower heart rate or blood pressure, including other antihypertensives and certain antipsychotics 2

Special Populations

Elderly patients may require lower starting doses (e.g., 10 mg twice daily) due to altered pharmacokinetics and increased sensitivity to beta blockade 2

Diabetic patients require extra caution as propranolol masks tachycardia and tremor associated with hypoglycemia, potentially delaying recognition of dangerous blood sugar drops 2, 3

Alternative Approach for Non-Responders

If no response occurs at 80 mg/day after 2-3 days, consider:

  • Switching to a 5-HT2a antagonist like mirtazapine 7.5-15 mg at bedtime, which has more compelling recent evidence 4
  • Adding an anticholinergic agent (though these provide only symptomatic relief) 4
  • Reducing or switching the offending antipsychotic if clinically feasible 4

References

Research

Propranolol in the treatment of neuroleptic-induced akathisia.

The American journal of psychiatry, 1984

Guideline

Medication Transition from Flupentixol/Melitracen to Propranolol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Propranolol Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of low-dose metoprolol in neuroleptic-induced akathisia.

Journal of clinical psychopharmacology, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.